» Articles » PMID: 28674324

Flow Mediated Dilatation As a Biomarker in Vascular Surgery Research

Overview
Date 2017 Jul 5
PMID 28674324
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial dysfunction is one of the hallmarks of atherogenesis, and correlates with many cardiovascular risk factors. One of the features of endothelial dysfunction is the loss of nitric oxide (NO) bioavailability, resulting in derangements in the vasodilatory response of the vessel wall. Flow mediated dilatation (FMD) of the brachial artery is an accepted method for non-invasive assessment of systemic endothelial function. FMD is examined extensively in the context of cardiovascular research, and has been utilised as a routine assessment in large cohorts such as the Framingham Heart Study, Young Finns Study, and Gutenberg Heart Study. However, FMD is less known in the context of vascular surgery research, despite the similarities between the underpinning disease mechanisms. This review will provide a summary of FMD in terms of its history of development and the conduct of the test in research settings. It will further highlight the key literature of FMD as a biomarker for vascular surgeons, particularly in the context of abdominal aortic aneurysms and lower limb peripheral arterial disease.

Citing Articles

Assessment of Endothelial Dysfunction in Patients with Kawasaki Disease: A Meta-Analysis.

Yu X, Wu D, Song G Rev Cardiovasc Med. 2024; 23(8):260.

PMID: 39076622 PMC: 11266953. DOI: 10.31083/j.rcm2308260.


Deletion of the aryl hydrocarbon receptor in endothelial cells improves ischemic angiogenesis in chronic kidney disease.

Palzkill V, Tan J, Yang Q, Morcos J, Laitano O, Ryan T Am J Physiol Heart Circ Physiol. 2023; 326(1):H44-H60.

PMID: 37921663 PMC: 11213484. DOI: 10.1152/ajpheart.00530.2023.


Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease.

Kavurma M, Bursill C, Stanley C, Passam F, Cartland S, Patel S Front Cardiovasc Med. 2022; 9:1054576.

PMID: 36465438 PMC: 9709122. DOI: 10.3389/fcvm.2022.1054576.


Flow-Mediated Dilatation in the Assessment of Coronary Heart Disease: A Meta-Analysis.

Xiao X, Li X, Xiao X, Wang J, Liu D, Deng Z Cardiol Res Pract. 2022; 2022:7967324.

PMID: 36213460 PMC: 9534706. DOI: 10.1155/2022/7967324.


Endothelial Dysfunction in the Pathogenesis of Abdominal Aortic Aneurysm.

DeRoo E, Stranz A, Yang H, Hsieh M, Se C, Zhou T Biomolecules. 2022; 12(4).

PMID: 35454098 PMC: 9030795. DOI: 10.3390/biom12040509.


References
1.
Anderson T, Meredith I, Yeung A, Frei B, Selwyn A, Ganz P . The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332(8):488-93. DOI: 10.1056/NEJM199502233320802. View

2.
Irace C, Tripolino C, Scavelli F, Carallo C, Gnasso A . Brachial Low-Flow-Mediated Constriction is Associated with Delayed Brachial Flow-Mediated Dilation. J Atheroscler Thromb. 2015; 23(3):355-63. DOI: 10.5551/jat.32060. View

3.
Iwamoto A, Kajikawa M, Maruhashi T, Iwamoto Y, Oda N, Kishimoto S . Vascular Function and Intima-media Thickness of a Leg Artery in Peripheral Artery Disease: A Comparison of Buerger Disease and Atherosclerotic Peripheral Artery Disease. J Atheroscler Thromb. 2016; 23(11):1261-1269. PMC: 5113743. DOI: 10.5551/jat.35436. View

4.
Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M . Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol. 2008; 51(20):1953-8. DOI: 10.1016/j.jacc.2008.01.049. View

5.
Kajikawa M, Maruhashi T, Hida E, Iwamoto Y, Matsumoto T, Iwamoto A . Combination of Flow-Mediated Vasodilation and Nitroglycerine-Induced Vasodilation Is More Effective for Prediction of Cardiovascular Events. Hypertension. 2016; 67(5):1045-52. DOI: 10.1161/HYPERTENSIONAHA.115.06839. View